Home >> Industry News >> Australian News
Australian News
  • Also available via:

ACO Calling Optometrists That Are Not Therapeutically Qualified PDF
Submit Your News
Australian News
Friday, 04 September 2015

Candidates at the inaugural graduation ceremony ACO-COTThe Australian College of Optometry (ACO) offers a Certificate in Ocular Therapeutics (ACO-COT) and places are still available for the course commencing 14 September. This online course is accredited and on successful completion will enable the prescribing and administering of medicines for the treatment of ocular conditions in Australia and New Zealand.

Already more than 150 optometrists have commenced our Certificate in Ocular Therapeutics since February 2014.The course has proven to be very popular from participants across Australia, New Zealand and overseas. In particular those that require a flexible style of study have found the course to be suitable to their needs. An ACO-COT candidate, who works in a rural practice and juggles family, work and study said: "If I can do it...anyone can!...The study has already changed my approach. It has lifted my confidence immensely and made me a better clinician. As a mum who had to take some time out of the workforce for a while it's a great refresher too".

If you want to become therapeutically qualified but thought you could not complete the course due to your competing priorities, you may find this course to be a suitable option for you.

If you are interested, don't delay! Contact the ACO to discuss the study schedule and enrolment process. Please contact Dr Josephine Battista, ACO Clinical Course Manager, to discuss your interest in the course.

Contact details are as follows:
Telephone: +61 3 9349 7477
Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Optometry Board of Australia Reduces Registration Fees PDF
Submit Your News
Australian News
Thursday, 03 September 2015

The Optometry Board of Australia (the Board) has announced that the national registration fee for optometrists for 2015/16 has been reduced. The Board has reduced the registration fee to $325, which is $40 less than in the previous year. The new fee will apply from 9 September 2015 and cover the registration period for most practitioners of 1 December 2015 to 30 November 2016. The fee for practitioners whose principal place of practice is NSW is also $325.1

A fee schedule, including the fee arrangements for practitioners whose principal place of practice is NSW, will be published on the Board’s website.

The National Registration and Accreditation Scheme (the National Scheme) is funded by practitioners’ registration fees. The decision to reduce the fee ensures practitioners are not unduly burdened, but still provides sufficient income to allow the Board to meet its obligations in protecting the public.

Board Chair, Mr Ian Bluntish, said that the Board was pleased to be able to lower the fee for the third year in a row and still fulfil its regulatory obligations.

‘We will continue to monitor the costs of regulating the profession in the National Scheme, and with each year of regulation a more accurate picture is forming of the costs to do so, while also protecting the public. The National Scheme has provided a range of opportunities and we continue to review our approaches in the interests of nationally consistent and cost effective regulation,’ Mr Bluntish said.

Myopia Clinic Launched at UNSW Optometry PDF
Submit Your News
Australian News
Wednesday, 26 August 2015

In a response to the growing public health burden of myopia which is now one of the most significant causes of blindness, the UNSW Optometry Clinic has started a new Myopia Clinic, offering a service to identify patients who are at high risk of development of myopia and to implement appropriate interventions to slow down or halt myopia progression. The clinic will provide unique testing and treatment specific for myopia management.

Dr Pauline Kang and Ms Kathleen Watt both have strong research interests in myopia and myopia control and are excited to be offering this service through the clinic. The Myopia Clinic will use state-of-the-art equipment and offer evidence-based treatments to all patients. To share the expertise and facilities available, the clinic will also offer co-management of patients with local optometrists.

For more information call the UNSW Optometry Clinic on (02) 9385 4624.

Paragon Care To Acquire Designs For Vision PDF
Submit Your News
Australian News
Thursday, 20 August 2015

ParagoncareIntegrated service provider to Australia's health and aged care markets Paragon Care Limited has announced it has entered into conditional term sheets to acquire Designs For Vision Pty Ltd. Paragon Care is also to acquire Western Biomedical Pty Ltd and Meditron Pty Ltd. The total value of these acquisitions is $66.1 million. The acquisitions will be funded by a combination of debt and equity.

According to Paragon Care, the acquisitions are highly complementary with the existing business model and will add scale to Paragon’s customer centric product platform, while providing further product diversification. The acquisitions expand Paragon Care's geographical coverage into Western Australia, and also facilitate future expansion opportunities in a high growth, highly fragmented market. The Acquisitions are expected to be highly synergistic from a revenue point and deliver immediate earnings per share accretion on a pro-forma basis.

Commenting on the Acquisitions Paragon Care’s Managing Director Mr Mark Simari said, “The acquisitions are consistent with the Company’s strategy to become one of Australia’s leading providers of medical equipment and consumable products to the health and aged care sector throughout Australia and New Zealand. The new businesses will enhance the Company’s strong organic growth profile, while lowering overall risk through product and geographic diversification. All three businesses come with exceptional management and executive teams that will be retained post-acquisition and partner with Paragon to transition their businesses onto the Company’s healthcare platform”.

Design For Vision is to be acquired for $25.5 million which is more than six times the earnings of financial year 2015.

Designs For Vision has been a specialist provider of products to the ophthalmic and optometry sector for over 40 years. Using a global network Designs For Vision provides diagnostic and surgical products to a range of customers spanning across the healthcare sector. Designs for Vision represents in excess of 50 global companies, bringing together ever changing worldwide technologies in product to Australian and New Zealand markets. New suppliers are actively sourced either at overseas conferences or overseas companies seeking Designs For Vision out to represent them due to the outstanding reputation developed by Designs for Vision over 40 years of successfully servicing their clientele.

Chinese Company Jangho Makes Offer for Vision Eye Institute PDF
Submit Your News
Australian News
Friday, 14 August 2015

Vision Eye InstituteVision Eye Institute Limited (Vision) announced yesterday that it has entered into a takeover bid implementation deed (Implementation Deed) with Chinese company Jangho Group Co., Ltd (Jangho) under which Jangho (or a wholly owned subsidiary) has agreed to make an all-cash off-market takeover offer for Vision. Jangho will offer to acquire all the outstanding voting shares in Vision that it does not already own for $1.10 cash per share (the Jangho Offer). Jangho presently holds a 19.99% stake in Vision and its Bidder’s Statement will detail how and when Vision shareholders can accept the Jangho Offer.

The signing of the Implementation Deed follows recent discussions between Jangho and the Vision Board about the future direction and growth of Vision. Each Vision director, including all doctor executive directors and non-executive directors, recommends that Vision shareholders accept the Jangho offer, subject to there being no superior alternative proposal. Each director intends to accept the Jangho offer in respect of the Vision shares they own or control, subject to no superior alternative proposal being received.

Vision further communicated that Vision shareholders are reminded that Vision directors unanimously continue to recommend that Vision shareholders reject the inferior all-scrip off-market takeover offer from Pulse Health Limited (Pulse) (the Pulse offer) and continue to ignore all documents received from Pulse.

Vision Eye Institute's Chairman, Mr Shane Tanner said: "The Vision Board considers that the Jangho Offer highlights the strategic value of our business, in particular its day surgery clinics, the program of strategic initiatives being undertaken and Vision’s strong prospects for future growth. The Vision Board of Directors unanimously intend to recommend the Jangho Offer, subject to no superior alternative proposal being received. Vision has a long history of charitable, philanthropic and educational activities in SE Asia and the proposed partnership with Jangho provides further opportunities to build on and expand these activities."

U2 Lead Singer Bono, Revo Eyewear, and BHVI Join Forces to Fight Vision Impairment PDF
Submit Your News
Australian News
Thursday, 13 August 2015

Revo - Bono - BHVIEyewear brand Revo and U2 lead singer Bono have joined forces with the Brien Holden Vision Institute (BHVI) to eliminate avoidable blindness and vision impairment.

"Eye tests and eye examinations are at the front line of eye care. But for millions of people without access, the simplest problems go untreated. It’s unnecessary and avoidable," said Kovin Naidoo. Kovin Naidoo is the Interim CEO of the Brien Holden Vision Institute, following the passing of Professor Brien Holden in Sydney on 28 July.

When consumers purchases Revo sunglasses, $10 from the sale of every pair will be donated by Revo to the "Buy Vision, Give Sight" initiative. To execute the initiative, Revo and Bono are partnering with the Brien Holden Vision Institute to provide sustainable solutions for eye care and end avoidable blindness and vision impairment in under-resourced communities.

Bono, who has a long track record in global health, particularly as an activist in the fight against HIV/AIDS, was diagnosed with glaucoma 20 years ago. His experience with glaucoma, for which he has received excellent treatment, has made him determined to find a way to increase access to frontline eye health services for others.

The funds donated by Revo will help pay for basic eye care services, particularly eye tests and prescription glasses, and also build stronger eye care services in target communities for the longer term by training local people to provide eye care and detect eye diseases.

<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 1 of 116